s response to the tumor microenvironment, which will propel the testing of anti-PD1 or anti-PD1/anti- CTLA4 combinations with epigenetic inhibitors Tara Miller Melanoma Foundation-MRA Young Investigator Award, 2017-2020 Kunal Rai, University of Texas M.D. Anderson Cancer Center A human T cell genetic scree